Bruce L. Downey's most recent trade in C4 Therapeutics Inc was a trade of 32,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 20, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
C4 Therapeutics Inc | Bruce L. Downey | Director | 20 Jun 2024 | 32,500 | 32,500 | - | - | Stock Option (Right to Buy) | ||
Cardinal Health | Bruce L. Downey | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jun 2023 | 1,200 | 52,729 (0%) | 0% | 0 | Common Shares | |
C4 Therapeutics Inc | Bruce L. Downey | Director | 15 Jun 2023 | 26,000 | 26,000 | - | - | Stock Option (Right to Buy) | ||
Cardinal Health | Bruce L. Downey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2022 | 2,308 | 53,929 (0%) | 0% | 0 | Common Shares | |
C4 Therapeutics Inc | Bruce L. Downey | Director | 22 Jun 2022 | 23,500 | 23,500 | - | - | Stock Option (Right to Buy) | ||
Cardinal Health | Bruce L. Downey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 3,709 | 51,621 (0%) | 0% | 0 | Common Shares | |
C4 Therapeutics Inc | Bruce L. Downey | Director | 15 Jun 2021 | 23,500 | 23,500 | - | - | Stock Option (Right to Buy) | ||
Cardinal Health | Bruce L. Downey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2020 | 3,339 | 47,912 (0%) | 0% | 0 | Common Shares | |
C4 Therapeutics Inc | Bruce L. Downey | Director | 06 Oct 2020 | 2,128,571 | 0 | - | - | Series B Preferred Stock | ||
C4 Therapeutics Inc | Bruce L. Downey | Director | 06 Oct 2020 | 2,000,000 | 0 | - | - | Series A Preferred Stock | ||
C4 Therapeutics Inc | Bruce L. Downey | Director | 06 Oct 2020 | 252,394 | 489,542 | - | - | Common Stock | ||
C4 Therapeutics Inc | Bruce L. Downey | Director | 06 Oct 2020 | 237,148 | 237,148 | - | - | Common Stock | ||
C4 Therapeutics Inc | Bruce L. Downey | Director | 01 Oct 2020 | 17,786 | 17,786 | - | - | Stock Option (Right to Buy) |